Close

Agios Pharma (AGIO) Prices 3.37M Share Common Stock Offering for Proceeds of ~$150M

Go back to Agios Pharma (AGIO) Prices 3.37M Share Common Stock Offering for Proceeds of ~$150M

Agios Announces Pricing of $150 Million Public Offering of Common Stock

September 14, 2016 8:14 PM EDT

CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) today announced that it has priced an underwritten public offering of 3,370,786 shares of common stock at a price to the public of $44.50 per share, before underwriting discounts, which would result in aggregate gross proceeds of approximately $150 million. All of the shares in the offering are to be sold by Agios. Agios has also granted the underwriters a 30-day option to purchase up to an additional 505,617 shares of common stock on the same terms and conditions. Closing of the offering is... More

Agios Announces Proposed Offering of Common Stock

September 13, 2016 4:13 PM EDT

CAMBRIDGE, Mass., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) today announced that it is offering to sell, subject to market and other conditions, up to $150 million of its common stock in an underwritten public offering. Agios also intends to grant the underwriters a 30-day option to purchase from it up to an additional $22.5 million of shares. All of the shares in the offering are to be sold by Agios. The proceeds of the offering are expected to be used to fund the companys clinical and research development activities. The... More